Georgia Sen. Jon Ossoff wants limits on “prior authorization” practices that delay or deny care, citing harms to patients and pressure on families.
Health care coverage can sound like a safety net—until a request gets stuck in a procedural bottleneck.
Sen. Jon Ossoff of Georgia is urging the U.S. Senate to move toward banning or sharply restricting insurance companies that delay or deny medically necessary care, arguing that Americans pay high premiums while still being forced to wait for approvals that can affect real outcomes.
In a letter to Senate leaders. Ossoff condemned what he described as abuses of “prior authorization. ” a common insurance process that requires providers to obtain insurer approval before certain treatments. tests. or medications are covered.. He said patients—including in Georgia—are being denied “medically necessary care” despite paying record premiums.. His focus is not only on outright denials. but on the delays that can come when decisions take weeks. and when approvals are granted at an insurer’s discretion.
The senator’s concern is that prior authorization has become a system that shifts clinical decisions away from doctors and toward administrative gatekeeping.. Ossoff pointed to cases where Georgians were allegedly denied life-saving medication and forced to wait months for care they need.. For families. that kind of timeline can change the meaning of “coverage” from a promise to a question mark—especially for chronic conditions. serious diagnoses. or when a medication is the difference between stability and decline.
A key argument in Ossoff’s letter is that these practices can be harmful beyond inconvenience.. He cited a study from Johns Hopkins University finding that prior authorization is linked to worse health outcomes. including increased hospitalizations. longer hospital stays. and lower survival rates.. The point is consequential: even when care is ultimately approved, the period of delay can carry medical risk.
Ossoff also referenced data highlighting how widespread the problem appears to be.. He cited reporting from KFF indicating that nearly all seniors enrolled in Medicare Advantage plans require prior authorization for some services. and that more than four million requests were denied in 2024.. The senator also pointed to a large number of denied in-network claims in 2024 under the Affordable Care Act—and noted that fewer than 1% were appealed.
That last detail matters because it suggests many denials may never be challenged. whether due to time constraints. paperwork barriers. or confusion about appeal processes.. In real life. even patients determined to push back can be overwhelmed when they are also trying to coordinate appointments. manage costs. and handle illness.. When the system’s friction is built into the process. the burden shifts to people who may have the least capacity to navigate it.
Ossoff’s proposed legislative direction would. at minimum. aim to hold insurance companies accountable for improper denials. require faster responses to authorization requests. and restrict retroactive denials—except where fraud or misrepresentation is involved.. The underlying theme is simple: approvals should not be a moving target. and patients should not be left in a crisis while insurers review medical necessity.
The push also reflects a broader political focus on health care administration rather than only on pricing.. In Washington, coverage debates often center on premiums, deductibles, and plan design.. But if prior authorization functions as a de facto rationing mechanism—whether intentional or not—then the discussion has to include the mechanics of access: how quickly decisions are made. how often they are reversed. and what safeguards exist when errors occur.
Ossoff’s efforts build on prior action.. Earlier this month. he launched an inquiry with Mehmet Oz. administrator of the Centers for Medicare and Medicaid Services. over insurance practices contributing to delays in care.. He has also backed bipartisan proposals involving hearing devices for children. transparency in generic drug approvals. and reducing Medicaid delays for specialty care—indicating a pattern of focusing on implementation problems that affect patients after a policy is already on paper.
For voters, the stakes are practical.. A denial or delay can mean switching medications. postponing therapy. driving up out-of-pocket costs. or facing worsening health while waiting for paperwork to catch up to clinical reality.. Ossoff’s argument is that these outcomes are not edge cases; they are predictable consequences of a system that may allow insurers to operate with too much discretion.
If the Senate takes up legislation along these lines. the debate will likely turn on balancing insurer oversight with clinical urgency—how to stop unreasonable denials without creating new loopholes.. The political challenge will be translating patient protection into enforceable rules: timelines for responses. standards for “medical necessity. ” and consequences when approvals are improperly withheld.. Families can’t afford another cycle where a process replaces care; they need clear. faster access when health is on the line.